相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in Citric Acid Cycle and Nucleoside Metabolism Are Associated with Anthracycline Cardiotoxicity in Patients with Breast Cancer
Aarti Asnani et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2020)
Signaling Pathways Underlying Anthracycline Cardiotoxicity
Valentina Sala et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents
B. Pajak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2?mediated activation of forkhead box O1
Peng Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition
Jaewon Oh et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease
Joseph Pierre Aboumsallem et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Insight into the mechanism of ferroptosis inhibition by ferrostatin-1
Giovanni Miotto et al.
REDOX BIOLOGY (2020)
Common risk factors for heart failure and cancer
Wouter C. Meijers et al.
CARDIOVASCULAR RESEARCH (2019)
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer
Tomoya Kitani et al.
CIRCULATION (2019)
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity
Michele Russo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Yanhua Mou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Ferroptosis as a target for protection against cardiomyopathy
Xuexian Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Chowdhury S. Abdullah et al.
SCIENTIFIC REPORTS (2019)
Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy
Sudhir Pandey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Cancer and heart disease: associations and relations
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function
Panxia Wang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Cardiovascular Toxicities in Pediatric Cancer Survivors
Thomas D. Ryan et al.
CARDIOLOGY CLINICS (2019)
Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection
Martino Deidda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The role of adipose triglyceride lipase in lipid and glucose homeostasis: lessons from transgenic mice
Michael J. Trites et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Dietary metabolism, the gut microbiome, and heart failure
W. H. Wilson Tang et al.
NATURE REVIEWS CARDIOLOGY (2019)
Cardiac molecular pathways influenced by doxorubicin treatment in mice
Ben F. Bulten et al.
SCIENTIFIC REPORTS (2019)
Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure
Chang-Myung Oh et al.
KOREAN CIRCULATION JOURNAL (2019)
AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair
Lilach Moyal et al.
INVESTIGATIONAL NEW DRUGS (2018)
Beyond gut feelings: how the gut microbiota regulates blood pressure
Francine Z. Marques et al.
NATURE REVIEWS CARDIOLOGY (2018)
Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells
Chenke Xu et al.
BIOCHEMICAL PHARMACOLOGY (2018)
AMPK blunts chronic heart failure by inhibiting autophagy
Yanhui Li et al.
BIOSCIENCE REPORTS (2018)
Cardiovascular Metabolomics
Robert W. McGarrah et al.
CIRCULATION RESEARCH (2018)
Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge
Pietro Ameri et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling
Peter Reichardt et al.
FUTURE ONCOLOGY (2018)
Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: Are There Unsuspected Confounders? REPLY
Gianmario Sambuceti et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
Rita Zilinyi et al.
MOLECULES (2018)
Metabolic remodelling in heart failure
Edoardo Bertero et al.
NATURE REVIEWS CARDIOLOGY (2018)
Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes
Teresa Cunha-Oliveira et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
Gilda Varricchi et al.
FRONTIERS IN PHYSIOLOGY (2018)
AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis
Dong Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity
Arun Sharma et al.
NATURE PROTOCOLS (2018)
Autophagy: an adaptive physiological countermeasure to cellular senescence and ischaemia/reperfusion-associated cardiac arrhythmias
Istvan Lekli et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET/CT Observation
Matteo Bauckneht et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke
Q-z Tuo et al.
MOLECULAR PSYCHIATRY (2017)
Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite
Jan Bures et al.
TOXICOLOGY (2017)
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Navid Koleini et al.
ONCOTARGET (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression
James T. Thackeray et al.
JCI INSIGHT (2017)
Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes
Nadjib Hammoudi et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Effect of androgen deprivation therapy on arterial stiffness and serum lipid profile changes in patients with prostate cancer: a prospective study of initial 6-month follow-up
Ryo Oka et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism
Wei Ge et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Insulin Signaling and Heart Failure
Shavonn C. Harper et al.
CIRCULATION RESEARCH (2016)
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs
Valentina Mercurio et al.
JOURNAL OF CARDIAC FAILURE (2016)
Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle
Edson Alves de Lima Junior et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
MicroRNAs for Restenosis and Thrombosis After Vascular Injury
Christian Riehle et al.
CIRCULATION RESEARCH (2016)
Doxorubicin Regulates Autophagy Signals via Accumulation of Cytosolic Ca2+ in Human Cardiac Progenitor Cells
Ji Hye Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
J. Mark Brown et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells
Shiwei Deng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
Jingyuan Fu et al.
CIRCULATION RESEARCH (2015)
Inter-individual differences in the gene content of human gut bacterial species
Ana Zhu et al.
GENOME BIOLOGY (2015)
Dexrazoxane Exposure and Risk of Secondary Acute Myeloid Leukemia in Pediatric Oncology Patients
Alix E. Seif et al.
PEDIATRIC BLOOD & CANCER (2015)
Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease
W. H. Wilson Tang et al.
CIRCULATION RESEARCH (2015)
The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration
David Heras-Sandoval et al.
CELLULAR SIGNALLING (2014)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy
Aijun Sun et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Prevention of Anthracycline-Induced Cardiotoxicity
Pimprapa Vejpongsa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling
Rimpy Dhingra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Synchronized renal tubular cell death involves ferroptosis
Andreas Linkermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Insulin resistance protects the heart from fuel overload in dysregulated metabolic states
Heinrich Taegtmeyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Targeted Cancer Therapy with a 2-Deoxyglucose-Based Adriamycin Complex
Jie Cao et al.
CANCER RESEARCH (2013)
Cardiac Insulin-Resistance and Decreased Mitochondrial Energy Production Precede the Development of Systolic Heart Failure After Pressure-Overload Hypertrophy
Liyan Zhang et al.
CIRCULATION-HEART FAILURE (2013)
Doxorubicin treatment inhibits PPARγ and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models
Sankarganesh Arunachalam et al.
FEBS LETTERS (2013)
Involvement of ferritin heavy chain in the preventive effect of metformin against doxorubicin-induced cardiotoxicity
Mari C. Asensio-Lopez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia
Zdenek Racil et al.
HAEMATOLOGICA (2013)
Cardiomyocyte specific adipose triglyceride lipase overexpression prevents doxorubicin induced cardiac dysfunction in female mice
Jeevan Nagendran et al.
HEART (2013)
Metabolic roles of AMPK and metformin in cancer cells
Yeon Kyung Choi et al.
MOLECULES AND CELLS (2013)
FOXOs: signalling integrators for homeostasis maintenance
Astrid Eijkelenboom et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Creatine Kinase-Overexpression Improves Myocardial Energetics, Contractile Dysfunction and Survival in Murine Doxorubicin Cardiotoxicity
Ashish Gupta et al.
PLOS ONE (2013)
Cardiac Toxicity of Anticancer Agents
Alessandro Colombo et al.
CURRENT CARDIOLOGY REPORTS (2013)
Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress
Severine Gratia et al.
CARDIOVASCULAR RESEARCH (2012)
Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes
Tomonori Kawaguchi et al.
CARDIOVASCULAR RESEARCH (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Short-Chain Fatty Acid Propionate Alleviates Akt2 Knockout-Induced Myocardial Contractile Dysfunction
Linlin Li et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity
Nataly Tarasenko et al.
INVESTIGATIONAL NEW DRUGS (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer (vol 102, pg 39, 2009)
Nancy L. Keating
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Autophagy, nutrition and immunology
Ana Maria Cuervo et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Functional interactions between the gut microbiota and host metabolism
Valentina Tremaroli et al.
NATURE (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Berberine Inhibits Doxorubicin-Triggered Cardiomyocyte Apoptosis via Attenuating Mitochondrial Dysfunction and Increasing Bcl-2 Expression
Xiuxiu Lv et al.
PLOS ONE (2012)
Symptomatic atherosclerosis is associated with an altered gut metagenome
Fredrik H. Karlsson et al.
NATURE COMMUNICATIONS (2012)
The role of insulin resistance in the development of muscle wasting during cancer cachexia
Mary A. Honors et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2012)
A dual role for Ca2+ in autophagy regulation
Jean-Paul Decuypere et al.
CELL CALCIUM (2011)
Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice
Zhonglin Xie et al.
DIABETES (2011)
Caloric Restriction Mimetic 2-Deoxyglucose Antagonizes Doxorubicin-induced Cardiomyocyte Death by Multiple Mechanisms
Kai Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Insulin Receptor Substrates Irs1 and Irs2 Coordinate Skeletal Muscle Growth and Metabolism via the Akt and AMPK Pathways
Yun Chau Long et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Joungmok Kim et al.
NATURE CELL BIOLOGY (2011)
Calorie Restriction: Is AMPK a Key Sensor and Effector?
Carles Canto et al.
PHYSIOLOGY (2011)
ALDH2 in alcoholic heart diseases: Molecular mechanism and clinical implications
Yingmei Zhang et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass
Deise Raquel Barpe et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death
Satoru Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy
Rui A. Carvalho et al.
TOXICOLOGY (2010)
Transgenic Overexpression of Aldehyde Dehydrogenase-2 Rescues Chronic Alcohol Intake-Induced Myocardial Hypertrophy and Contractile Dysfunction
Thomas A. Doser et al.
CIRCULATION (2009)
Doxorubicin: The Good, the Bad and the Ugly Effect
Cristina Carvalho et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure
Pasquale Gallo et al.
CARDIOVASCULAR RESEARCH (2008)
Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice
Anne Granger et al.
FASEB JOURNAL (2008)
Doxorubicin increases the susceptibility of brain mitochondria to Ca2+-induced permeability transition and oxidative damage
Susana Cardoso et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo
Olga Popelova et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Insulin-resistant cardiomyopathy
Ronald M. Witteles et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Li Wen et al.
NATURE (2008)
Mechanisms of disease: Cardiac plasticity
Joseph A. Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The role of FoxO in the regulation of metabolism
D. N. Gross et al.
ONCOGENE (2008)
Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart
Che-Hong Chen et al.
SCIENCE (2008)
Iron chelation by clinically relevant anthracyclines: Alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking
X. Xu et al.
MOLECULAR PHARMACOLOGY (2008)
Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib
M. Breccia et al.
LEUKEMIA RESEARCH (2007)
Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity
Mayurranjan S. Mitra et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Yi Lisa Lyu et al.
CANCER RESEARCH (2007)
Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells
Metin Kurtoglu et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity
A. Rephaeli et al.
BRITISH JOURNAL OF CANCER (2007)
Dexrazoxane-Associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease
Cameron K. Tebbi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adriamycin-induced oxidative mitochondrial cardiotoxicity
J. M. Berthiaume et al.
CELL BIOLOGY AND TOXICOLOGY (2007)
Role of anthracyclines in the era of targeted therapy
Hernan Cortes-Funes et al.
CARDIOVASCULAR TOXICOLOGY (2007)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Akt2 regulates cardiac metabolism and cardiomyocyte survival
Brian DeBosch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
AMP-activated protein kinase signaling in metabolic regulation
Yun Chau Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy
Yongli Kong et al.
CIRCULATION (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Molecular pharmacology of the interaction of anthracyclines with iron
XX Xu et al.
MOLECULAR PHARMACOLOGY (2005)
Cancer chemotherapy and drug metabolism
DS Riddick et al.
DRUG METABOLISM AND DISPOSITION (2005)
Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply
M Tokarska-Schlattner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
AMP-activated protein kinase: A master switch in glucose and lipid metabolism
DG Hardie
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2004)
The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin
BB Hasinoff et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors
CL Antos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: Inhibition of the ferritin iron mobilization pathway
JC Kwok et al.
MOLECULAR PHARMACOLOGY (2003)
Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth
Y Taniyama et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Effect of streptozotocin-induced hyperglycaemia on intravenous pharmacokinetics and acute cardiotoxicity of doxorubicin in rats
OA Al-Shabanah et al.
PHARMACOLOGICAL RESEARCH (2000)
分享论文
